2013
DOI: 10.3109/10717544.2013.838717
|View full text |Cite
|
Sign up to set email alerts
|

Dual thermoresponsive and pH-responsive self-assembled micellar nanogel for anticancer drug delivery

Abstract: In this article, we prepared a dual thermoresponsive and pH-responsive self-assembled micellar nanogel for anticancer drug delivery by using a degradable pH-responsive ketal derivative, mPEG2000-Isopropylideneglycerol (mPEG-IS, PI) polymer. The purpose of this study is to develop an injectable dual-responsive micellar nanogel system which has a sol-gel phase transition by the stimulation of body temperature with improved stability and biocompatibility as a controlled drug delivery carrier for cancer therapy. T… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
28
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 42 publications
(28 citation statements)
references
References 25 publications
0
28
0
Order By: Relevance
“…A series of chemical anticancer drugs have been well developed and clinically used in these decades, such as doxorubicin (DOX) (Zhang et al, 2012;Fabbri et al, 2016), paclitaxel (PTX) (Markman & Mekhail, 2002;Yang et al, 2018), and camptothecin (CPT) (Venditto & Simanek, 2010;Llin as et al, 2018); however, these drugs are limited in the further clinical applications due to the serious side-effects caused by offtargeting and low therapeutic efficacy (Jungk et al, 2016;Yoshizawa et al, 2016). To overcome these obstacles, nanoscale drug delivery systems (DDSs) have attracted more and more attention and been extensively investigated (Chen et al, 2014), such as polymeric micelles (PMs), nanoparticles (NPs), prodrug, and liposome (Zhang et al, 2016;Zylberberg & Matosevic, 2016;Huang et al, 2018;Li et al, 2018;Dong et al, 2019). These effective DDSs are used to deliver hydrophobic or hydrophilic therapeutics which exhibit poor pharmacokinetics and high cytotoxicity to the site of tumor (Wang et al, 2016;Qin et al, 2017;Li et al, 2019).…”
Section: Introductionmentioning
confidence: 99%
“…A series of chemical anticancer drugs have been well developed and clinically used in these decades, such as doxorubicin (DOX) (Zhang et al, 2012;Fabbri et al, 2016), paclitaxel (PTX) (Markman & Mekhail, 2002;Yang et al, 2018), and camptothecin (CPT) (Venditto & Simanek, 2010;Llin as et al, 2018); however, these drugs are limited in the further clinical applications due to the serious side-effects caused by offtargeting and low therapeutic efficacy (Jungk et al, 2016;Yoshizawa et al, 2016). To overcome these obstacles, nanoscale drug delivery systems (DDSs) have attracted more and more attention and been extensively investigated (Chen et al, 2014), such as polymeric micelles (PMs), nanoparticles (NPs), prodrug, and liposome (Zhang et al, 2016;Zylberberg & Matosevic, 2016;Huang et al, 2018;Li et al, 2018;Dong et al, 2019). These effective DDSs are used to deliver hydrophobic or hydrophilic therapeutics which exhibit poor pharmacokinetics and high cytotoxicity to the site of tumor (Wang et al, 2016;Qin et al, 2017;Li et al, 2019).…”
Section: Introductionmentioning
confidence: 99%
“…14 More recently, research has focused on materials with dual functionality, where two stimuli are combined. 15 In particular, materials showing dual temperature and pH response characteristics have been developed for drug delivery applications, 16 demonstrating efficient tailored release. 17,18 The area of stimuli-triggered drug delivery has witnessed significant advances, with systems such as polymersomes, 19 dendrimers 20 and nanocomposite hydrogels 21 all showing promising results.…”
Section: Introductionmentioning
confidence: 99%
“…In vitro, this nanogel system demonstrated pH-sensitive release of its payload, doxorubicin, demonstrating that doxorubicin release was significantly accelerated when placed in the acidic medium (pH 6.8) [ 22 ]. Chen et al prepared dual thermo- and pH-sensitive micellar nanogels composed of mPEG-isopropylideneglycerol [ 23 ]. First, pH-responsive micelles carrying paclitaxel were formed and then incorporated into the thermosensitive nanogel matrix.…”
Section: Smart Nanogels For Pharmaceutical and Biomedical Applicatmentioning
confidence: 99%
“…This drug delivery system was structured to primarily develop injectable nanogels which stay in a sol-state at room temperature, but forms a gel at body temperature. Paclitaxel incorporated in the micelles with a particle size of 100–200 nm was released at an elevated rate in an acidic medium which mimics the extracellular environment of tumor [ 23 ]. Chen et al used the glutathione gradient (four times greater in concentration in tumors) to reduce disulfide bonds and activate the destabilization of the nanogel [ 24 ].…”
Section: Smart Nanogels For Pharmaceutical and Biomedical Applicatmentioning
confidence: 99%